Nuveen Asset Management, LLC Ardelyx, Inc. Transaction History

Nuveen Asset Management, LLC

$340 Billion
Q4 2024

A detailed history of Nuveen Asset Management, LLC transactions in Ardelyx, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 2,170,999 shares of ARDX stock, worth $12.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,170,999

Previous 2,166,961 0.19%

Holding current value

$12.7 Million

Previous $14.9 Million 24.82%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$4.49 - $6.85 $18,130 - $27,660	4,038 Added 0.19%	2,170,999 $11.2 Million
Q3 2024 Nov 14, 2024	BUY	$5.28 - $7.57 $20,423 - $29,280	3,868 Added 0.18%	2,166,961 $14.9 Million
Q2 2024 Aug 09, 2024	SELL	$5.89 - $9.31 $6.07 Million - $9.6 Million	-1,031,209 Reduced 32.28%	2,163,093 $16 Million
Q1 2024 May 13, 2024	BUY	$6.05 - $9.74 $6.57 Million - $10.6 Million	1,086,411 Added 51.54%	3,194,302 $23.3 Million
Q4 2023 Feb 14, 2024	BUY	$3.29 - $6.64 $563,379 - $1.14 Million	171,240 Added 8.84%	2,107,891 $13.1 Million

Q3 2023 Nov 14, 2023	BUY	$3.3 - $4.83 $4.43 Million - $6.49 Million	1,342,937 Added 226.19%	1,936,651 $7.9 Million
Q2 2023 Aug 14, 2023	BUY	$3.23 - $4.95 $1.92 Million - $2.94 Million	593,714 New	593,714 $2.01 Million
Q2 2022 Aug 15, 2022	SELL	$0.51 - $1.17 $130,633 - $299,688	-256,144 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$0.86 - $1.7 $23,077 - $45,617	-26,834 Reduced 9.48%	256,144 $1.92 Million
Q3 2021 Nov 12, 2021	SELL	$1.27 - $8.17 $213,337 - $1.37 Million	-167,982 Reduced 37.25%	282,978 $2.12 Million
Q2 2021 Aug 16, 2021	BUY	$6.55 - $8.98 $728,340 - $998,549	111,197 Added 32.73%	450,960 $3.42 Million
Q1 2021 May 17, 2021	BUY	$6.1 - $7.69 $165,157 - $208,206	27,075 Added 8.66%	339,763 $2.25 Million
Q4 2020 Feb 16, 2021	BUY	$5.05 - $7.1 $147,773 - $207,760	29,262 Added 10.32%	312,688 $2.02 Million
Q3 2020 Nov 16, 2020	SELL	$5.25 - $7.08 $195,751 - $263,984	-37,286 Reduced 11.63%	283,426 $1.49 Million
Q2 2020 Aug 14, 2020	BUY	$5.37 - $8.11 $184,212 - $278,205	34,304 Added 11.98%	320,712 $2.22 Million
Q1 2020 May 14, 2020	BUY	$4.35 - $8.79 $487,256 - $984,594	112,013 Added 64.23%	286,408 $1.63 Million
Q4 2019 Feb 14, 2020	SELL	$4.23 - $8.29 $1.42 Million - $2.79 Million	-336,362 Reduced 65.86%	174,395 $1.31 Million
Q3 2019 Nov 14, 2019	SELL	$2.15 - $6.28 $22,398 - $65,425	-10,418 Reduced 2.0%	510,757 $2.4 Million
Q2 2019 Aug 15, 2019	BUY	$2.49 - $3.73 $1.3 Million - $1.94 Million	521,175 New	521,175 $1.4 Million

Others Institutions Holding ARDX

# of Institutions

246

Shares Held

160M

Call Options Held

697K

Put Options Held

1.61M

View Full List

About ARDELYX, INC.

Ticker ARDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 154,636,000
Market Cap $908M
Description
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...

More about ARDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Ardelyx, Inc. Transaction History